Hamovis Capsule
Hamovis Capsule : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministère de la santé de Malaisie / NPRA, Pharmaceutical Products, CC BY 4.0
- Registration number
- MAL20086085T
- Type
- Natural product
- Published status
- PRODUCT APPROVED
- Licence holder
- WHITE HERON PHARMACEUTICAL SDN. BHD.
- Manufacturer
- WHITE HERON PHARMACEUTICAL SDN. BHD.
- Registration date
- 2025-08-22
- Published validity end
- 2030-08-22
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
- Conditions légales
Citrus aurantium L.: La quantité ingérée de p-synéphrine doit être inférieure à 20 mg par dose journalière recommandée. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants, aux femmes enceintes ou allaitantes et en cas de traitement anti-hypertenseur. La caféine et les sources de caféine ne sont pas autorisées dans les compléments alimentaires contenant Citrus aurantium L.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| Sophora japonica | Sophora japonica[92 mg,500 mg] | Not identified |
| Sanguisorba officinalis | Sanguisorba officinalis[58 mg,500 mg] | Not identified |
| Sophora japonica | Sophora japonica[58 mg,500 mg] | Not identified |
| Platycladus orientalis | Platycladus orientalis[50 mg,500 mg] | Not identified |
| Angelica sinensis | Angelica sinensis[50 mg,500 mg] | Not identified |
| Schizonepeta tenuifolia | Schizonepeta tenuifolia[42 mg,500 mg] | Not identified |
| Citrus aurantium | Citrus aurantium[42 mg,500 mg] | Not identified |
| Scutellaria baicalensis | Scutellaria baicalensis[42 mg,500 mg] | Not identified |
| Prunus mume | Prunus mume[41 mg,500 mg] | Not identified |
| Panax notoginseng | Panax notoginseng[25 mg,500 mg] | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Original register data
View published fields and their variants
- Active ingredients
- Sophora japonica[92 mg,500 mg],Sanguisorba officinalis[58 mg,500 mg],Sophora japonica[58 mg,500 mg],Platycladus orientalis[50 mg,500 mg],Angelica sinensis[50 mg,500 mg],Schizonepeta tenuifolia[42 mg,500 mg],Citrus aurantium[42 mg,500 mg],Scutellaria baicalensis[42 mg,500 mg],Prunus mume[41 mg,500 mg],Panax notoginseng[25 mg,500 mg]
- Valid until
- 2030-08-22
- Registration date
- 2025-08-22
- Published description
- NATURAL PRODUCT
- Licence holder
- WHITE HERON PHARMACEUTICAL SDN. BHD.
- Producer
- WHITE HERON PHARMACEUTICAL SDN. BHD.
- Published name
- Hamovis Capsule
- Published reference
- 202004063617T
- Registration number
- MAL20086085T
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL20086085T
Ministère de la santé de Malaisie / NPRA, Pharmaceutical Products, CC BY 4.0
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.